BE862213A - Derives de 5-fluoro-uracile et leur application en therapeutique - Google Patents

Derives de 5-fluoro-uracile et leur application en therapeutique

Info

Publication number
BE862213A
BE862213A BE183769A BE183769A BE862213A BE 862213 A BE862213 A BE 862213A BE 183769 A BE183769 A BE 183769A BE 183769 A BE183769 A BE 183769A BE 862213 A BE862213 A BE 862213A
Authority
BE
Belgium
Prior art keywords
uracil
therapeutics
fluoro
derivatives
application
Prior art date
Application number
BE183769A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of BE862213A publication Critical patent/BE862213A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE183769A 1976-12-24 1977-12-22 Derives de 5-fluoro-uracile et leur application en therapeutique BE862213A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51154941A JPS6052708B2 (ja) 1976-12-24 1976-12-24 ５−フルオロウラシル系化合物およびそれを含有する抗腫瘍剤

Publications (1)

Publication Number Publication Date
BE862213A true BE862213A (fr) 1978-04-14

Family

ID=15595270

Family Applications (1)

Application Number Title Priority Date Filing Date
BE183769A BE862213A (fr) 1976-12-24 1977-12-22 Derives de 5-fluoro-uracile et leur application en therapeutique

Country Status (14)

Country Link
US (1) US4130648A (fr)
JP (1) JPS6052708B2 (fr)
AU (1) AU519524B2 (fr)
BE (1) BE862213A (fr)
CA (1) CA1077483A (fr)
CH (1) CH636874A5 (fr)
DE (1) DE2757431A1 (fr)
ES (1) ES465406A1 (fr)
FR (1) FR2378779A1 (fr)
GB (1) GB1594840A (fr)
NL (1) NL7714205A (fr)
PH (1) PH12700A (fr)
SE (1) SE436208B (fr)
SU (2) SU827489A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1235864A1 (ru) * 1983-03-11 1986-06-07 Отделение ордена Ленина института химической физики АН СССР Нитроксильные производные 5-фторурацила,обладающие противоопухолевой активностью
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
DK197486A (da) * 1986-04-30 1987-10-31 Ferring Farma Lab 5-fluoruracilprodug
RU2191581C1 (ru) * 2001-11-16 2002-10-27 Нестерук Владимир Викторович Способ получения раствора фторурацила
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
WO2018129533A1 (fr) 2017-01-09 2018-07-12 Shuttle Pharmaceuticals, Llc Inhibiteurs sélectifs d'histone déacétylase pour le traitement d'une maladie humaine
US11407723B2 (en) 2018-01-09 2022-08-09 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324952B2 (fr) * 1973-11-28 1978-07-24

Also Published As

Publication number Publication date
ES465406A1 (es) 1978-09-16
JPS6052708B2 (ja) 1985-11-20
SE7714670L (sv) 1978-06-25
CH636874A5 (de) 1983-06-30
SU827489A1 (ru) 1981-05-07
FR2378779A1 (fr) 1978-08-25
AU519524B2 (en) 1981-12-10
GB1594840A (en) 1981-08-05
NL7714205A (nl) 1978-06-27
DE2757431A1 (de) 1978-06-29
CA1077483A (fr) 1980-05-13
JPS5379880A (en) 1978-07-14
SE436208B (sv) 1984-11-19
FR2378779B1 (fr) 1980-08-22
AU3182577A (en) 1979-06-28
US4130648A (en) 1978-12-19
PH12700A (en) 1979-07-20
SU795469A3 (ru) 1981-01-07

Similar Documents

Publication Publication Date Title
LU80619A1 (fr) Derives heterosidiques de pleuromutiline et leur utilisation therapeutique
BE856045A (fr) Nouveaux derives de cephalosporines et leur preparation
BE864828A (fr) Derives du cepheme, leur procede de preparation et leur application en therapeutique
FR2281916A1 (fr) Derives d'alcanediols et leur utilisation en cosmetique
BE896572A (fr) Benzoazacycloalkyl-spiro-imidazolidines leur preparation et leur application en therapeutique
FR2297046A1 (fr) Derives d'adamantane et leur application
FR2344522A1 (fr) Nouveaux derives de phenethylamine et leur application
BE862213A (fr) Derives de 5-fluoro-uracile et leur application en therapeutique
BE859221A (fr) Bis-carbamoylsulfures n-substitues et leur preparation
FR2352783A1 (fr) Derives polyprenyl-carboxyliques, leur procede de preparation et leur application en therapeutique
FR2352804A1 (fr) 4-quinazolinyl-guanidines, leur preparation et leur application en therapeutique
FR2398753B1 (fr) Derives de pyranochromone et leur application therapeutique
BE861355A (fr) Derives anilides et leur preparation
BE862568A (fr) Nouvelles piperazines disubstituees, leurs procedes de preparation et leur application en therapeutique
BE863402A (fr) Azacycloalcanes, azacycloalcenes et derives de ceux-ci, leur procede de preparation et leur application en therapeutique
BE845612A (fr) Derives de tetrazole-5-carboxamide et leur preparation
BE859979A (fr) Derives de la clavuline leur preparation et leur emploi
FR2343746A1 (fr) Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique
BE866100A (fr) Derives de composes du type inter-phenylene-prostaglandine et compositions pharmaceutiques en contenant
BE850552A (fr) 2-furanones et leur preparation
BE868686Q (fr) Derives de la nicotinoyl carnitine et leur emploi
BE856637A (fr) Nouvelles 7-b-oxyiminoacylcephalosporines et leur application en therapeutique
BE855393A (fr) Composition therapeutique a base de derives thiazoliques et sa preparation
BE850936A (fr) Hydroxyquinoleines et leur preparation
BE774447A (fr) Nouveaux derives de la salicylamide et leur application en therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: EISAI CO. LTD

Effective date: 19871231